SA517381763B1 - عملية لزيادة ثبات تركيب يشتمل على أحماض دهنية أوميغا-3 متعددة الروابط غير المشبعة - Google Patents

عملية لزيادة ثبات تركيب يشتمل على أحماض دهنية أوميغا-3 متعددة الروابط غير المشبعة

Info

Publication number
SA517381763B1
SA517381763B1 SA517381763A SA517381763A SA517381763B1 SA 517381763 B1 SA517381763 B1 SA 517381763B1 SA 517381763 A SA517381763 A SA 517381763A SA 517381763 A SA517381763 A SA 517381763A SA 517381763 B1 SA517381763 B1 SA 517381763B1
Authority
SA
Saudi Arabia
Prior art keywords
composition
polyunsaturated omega
lysine
compositions
stability
Prior art date
Application number
SA517381763A
Other languages
English (en)
Inventor
كنوب غونتر
شورام مايكل
لاتيننوفيتش ميلان
Original Assignee
إيفونيك اوبريشنز جي ام بي اتش
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SA517381763(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by إيفونيك اوبريشنز جي ام بي اتش filed Critical إيفونيك اوبريشنز جي ام بي اتش
Publication of SA517381763B1 publication Critical patent/SA517381763B1/ar

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/02Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/30Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/18Lipids
    • A23V2250/186Fatty acids
    • A23V2250/1882Polyunsaturated fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

يتعلق الاختراع الحالي بعمليات لزيادة ثبات التراكيب التي تشتمل على الأحماض الدهنية أوميغا-3 متعددة الروابط غير المشبعة polyunsaturated omega-3 fatty acids ضد الأكسدة oxidation. وتتضمن العمليات الخطوات التالية: (1) تزويد تركيب أولي starting composition يشتمل على مكون واحد على الأقل من حمض دهني أوميغا-3 متعدد الروابط غير المشبعة؛ (2) تزويد تركيب ليسين lysine؛ (3) خلط المحاليل المائية، المائية-الكحولية أو الكحولية للتركيب الأولي وتركيب الليسين lysine، وإخضاع الخليط الناتج لظروف التجفيف بالرش spray drying لاحقاً، وبالتالي يتشكل تركيب منتج صلب يشتمل على ملح واحد على الأقل من كاتيون cation مشتق من الليسين lysine مع أنيون anion مشتق من حمض دهني أوميغا-3 متعدد الروابط غير المشبعة polyunsaturated omega-3 fatty acid؛ ويظهر التركيب المنتج محتوى للمذيب solvent content (SC) مختار من المقادير التالية: SC أقل من 5٪ وزناً، SC أقل من 3٪ وزناً، SC أقل من 1٪ وزناً، SC أقل من 0.5٪ وزناً. ويتعلق الاختراع الحالي أيضاً بالتراكيب التي يمكن الحصول عليها عن طريق عمليات التجفيف بالرش هذه واستخدام هذه التراكيب ل
SA517381763A 2014-12-23 2017-06-18 عملية لزيادة ثبات تركيب يشتمل على أحماض دهنية أوميغا-3 متعددة الروابط غير المشبعة SA517381763B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14199989 2014-12-23

Publications (1)

Publication Number Publication Date
SA517381763B1 true SA517381763B1 (ar) 2021-06-06

Family

ID=52344991

Family Applications (1)

Application Number Title Priority Date Filing Date
SA517381763A SA517381763B1 (ar) 2014-12-23 2017-06-18 عملية لزيادة ثبات تركيب يشتمل على أحماض دهنية أوميغا-3 متعددة الروابط غير المشبعة

Country Status (25)

Country Link
US (2) US10798962B2 (ar)
EP (1) EP3236782B1 (ar)
JP (1) JP6861156B2 (ar)
KR (1) KR102584130B1 (ar)
CN (1) CN107105746B (ar)
AU (1) AU2015371376B2 (ar)
BR (1) BR112017013319B1 (ar)
CA (1) CA2969159A1 (ar)
CL (2) CL2017001614A1 (ar)
CO (1) CO2017005847A2 (ar)
DK (1) DK3236782T3 (ar)
ES (1) ES2781863T3 (ar)
HU (1) HUE048494T2 (ar)
IL (1) IL252481B (ar)
MX (1) MX2017007846A (ar)
MY (1) MY179033A (ar)
PE (1) PE20171083A1 (ar)
PH (1) PH12017501145A1 (ar)
PL (1) PL3236782T3 (ar)
RU (1) RU2706202C2 (ar)
SA (1) SA517381763B1 (ar)
SG (1) SG11201704396XA (ar)
TW (1) TWI695682B (ar)
WO (1) WO2016102323A1 (ar)
ZA (1) ZA201704820B (ar)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10888538B2 (en) * 2016-12-13 2021-01-12 Dsm Ip Assets B.V. PUFA salt formulations (I)
JP2020500855A (ja) * 2016-12-13 2020-01-16 ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. Pufa塩製剤(ii)
US11622952B2 (en) * 2017-08-15 2023-04-11 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
EP3586640A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
KR20210097153A (ko) * 2018-11-30 2021-08-06 에보니크 오퍼레이션즈 게엠베하 인지질 및 지방산 염의 분산액을 포함하는 제제
WO2020109480A1 (en) 2018-11-30 2020-06-04 Evonik Operations Gmbh Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm)
CN113395908A (zh) 2018-11-30 2021-09-14 赢创运营有限公司 包含巨大芽孢杆菌属益生菌菌株和多不饱和脂肪酸组分的制剂
US20220233487A1 (en) 2019-05-06 2022-07-28 Evonik Operations Gmbh Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids
EP3972430A1 (en) 2019-05-23 2022-03-30 Evonik Operations GmbH Preparation for use in enhancing formation of short-chain fatty acids (scfas)
KR20220041871A (ko) 2019-08-01 2022-04-01 에보니크 오퍼레이션즈 게엠베하 오메가-3 지방산 염 및 보스웰리아 종으로부터의 검 수지의 추출물을 포함하는 제제
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
US20220280388A1 (en) 2019-08-08 2022-09-08 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
EP4009961A1 (en) 2019-08-08 2022-06-15 Evonik Operations GmbH Solubility enhancement of poorly soluble actives
KR20220044543A (ko) 2019-08-08 2022-04-08 에보니크 오퍼레이션즈 게엠베하 고체 투여 형태를 제조하는 방법 및 윤활제
CA3146612A1 (en) 2019-08-08 2021-02-11 Evonik Operations Gmbh Down streaming process for the production of polyunsaturated fatty acid salts
EP4097202A4 (en) * 2020-01-30 2024-01-03 Silicycle Inc METHOD FOR PRODUCING SOLID NEUTRAL AMINO ACID SALTS OF POLYUNSATURATED FATTY ACIDS
IL294990A (en) * 2020-01-30 2022-09-01 Silicycle Inc A process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
EP4125437A1 (en) 2020-04-01 2023-02-08 Evonik Operations GmbH Preparation for use as vasorelaxant
US20230149336A1 (en) 2020-04-01 2023-05-18 Evonik Operations Gmbh Preparation for use as antioxidant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945049A (en) 1959-05-25 1960-07-12 Gen Mills Inc Salts of basic amino acids and linoleic acid
HU199775B (en) * 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
IT1264987B1 (it) 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
KR960013387A (ko) * 1994-10-13 1996-05-22 오동빈 Dha과립분말 및 그의 제조방법
CN1463745A (zh) * 2002-06-14 2003-12-31 丁强 一种全元营养素补充剂
US20140199313A1 (en) * 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
US7867538B2 (en) * 2005-12-20 2011-01-11 Archer Daniels Midland Company Processes of improving the quality of oil and products produced therefrom
KR20170042364A (ko) * 2006-06-05 2017-04-18 디에스엠 뉴트리셔널 프라덕츠 아게 개선된 쉘을 가지는 마이크로캡슐
WO2008003064A2 (en) 2006-06-29 2008-01-03 Martek Biosciences Corporation Sweetened oil compositions and methods of making
CA2704345C (en) * 2007-11-01 2016-07-26 Enzymotec Ltd. Lipid mixture for infant nutrition
DK2366766T3 (en) * 2010-03-09 2017-03-27 Stepan Specialty Products Llc Process for treating an edible oil and thus obtained oil
CA2803558C (en) * 2010-06-30 2018-05-29 Mochida Pharmaceutical Co., Ltd. .omega.3 fatty acid compound preparation
WO2014011895A2 (en) * 2012-07-11 2014-01-16 Thetis Pharmaceuticals Llc High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof

Also Published As

Publication number Publication date
CO2017005847A2 (es) 2017-08-31
PH12017501145A1 (en) 2018-03-05
WO2016102323A1 (en) 2016-06-30
MY179033A (en) 2020-10-26
AU2015371376A1 (en) 2017-06-22
CA2969159A1 (en) 2016-06-30
IL252481B (en) 2021-08-31
US20170360072A1 (en) 2017-12-21
ZA201704820B (en) 2019-06-26
PE20171083A1 (es) 2017-08-03
TW201639464A (zh) 2016-11-16
CL2020000141A1 (es) 2020-06-05
CL2017001614A1 (es) 2018-01-12
KR102584130B1 (ko) 2023-10-04
ES2781863T3 (es) 2020-09-08
AU2015371376B2 (en) 2020-04-23
HUE048494T2 (hu) 2020-07-28
EP3236782A1 (en) 2017-11-01
RU2706202C2 (ru) 2019-11-15
DK3236782T3 (da) 2020-04-27
JP2018502085A (ja) 2018-01-25
RU2017125962A (ru) 2019-01-24
CN107105746B (zh) 2020-11-10
IL252481A0 (en) 2017-07-31
RU2017125962A3 (ar) 2019-06-18
KR20170094788A (ko) 2017-08-21
PL3236782T3 (pl) 2020-06-29
US11805798B2 (en) 2023-11-07
TWI695682B (zh) 2020-06-11
CN107105746A (zh) 2017-08-29
BR112017013319B1 (pt) 2021-11-30
US10798962B2 (en) 2020-10-13
BR112017013319A2 (pt) 2018-04-10
EP3236782B1 (en) 2020-02-05
JP6861156B2 (ja) 2021-04-21
US20200375235A1 (en) 2020-12-03
SG11201704396XA (en) 2017-07-28
MX2017007846A (es) 2017-09-19

Similar Documents

Publication Publication Date Title
SA517381763B1 (ar) عملية لزيادة ثبات تركيب يشتمل على أحماض دهنية أوميغا-3 متعددة الروابط غير المشبعة
PH12017501144A1 (en) Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
MY190760A (en) Method of manufacturing a frozen confection with low sfa coating and product obtained
WO2009102845A3 (en) Food products containing omega-3 fatty acids
WO2014131422A3 (en) Fermented rapeseed feed ingredient
WO2015011724A3 (en) A novel omega -3 fatty acid composition with a plant extract
WO2017171423A3 (ko) 갈릭산 함량이 증진된 연 캘러스 추출물, 이의 제조방법 및 이를 함유하는 미백용 화장료 조성물
EA202090592A1 (ru) Композиция, содержащая растительное масло, источник органических кислот, фенольные соединения и аминокислоты
NZ747847A (en) Lipid compositions
WO2015171460A3 (en) Formulations of cyclophosphamide liquid concentrate
MX2022007275A (es) Composiciones de acidos biliares y compuestos de fenilbutirato.
WO2016142819A3 (en) Novel process for the preparation of ranolazine
WO2017093866A3 (en) An improved process for the preparation of indigo carmine
MX2017011792A (es) Metodo para fabricar acido furan-2,5-dicarboxilico (fdca) a partir de una solucion de sal.
WO2017064635A3 (en) Saroglitazar magnesium, compositions containing it, process for its preparation
EA033545B1 (ru) Композиции для нанесения покрытий на основе шеллака и эмульгатора и способы нанесения покрытия на продукт питания
BR112018000682A2 (pt) processo para a preparação de um produto de leite fermentado
FI20166034A (fi) Polttoainekoostumuksen valmistaminen
EP3642190A4 (en) PROCESS FOR MANUFACTURING ESTERS OF 2,5-FURANDICARBOXYLIC ACID
WO2017116188A3 (ko) 양이온성 지질의 선택적 합성 방법
PE20221451A1 (es) Producto alimenticio en polvo, semi terminado, basado en alimentos vegetales y un proceso para la produccion del mismo
NZ627378A (en) Milk and a process for its preparation
PH12018500790A1 (en) Coffee cream oil composition
MX2018012342A (es) Procedimiento de preparacion de un producto de hidrato de monoglicerido.
WO2016023833A3 (en) Process for production of branched alcohols, and fuel composition containing them